CB Scientific, Inc.
OTC:CBSC
0.1347 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2017 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.011 | 0.012 | 0.01 | 0.028 | 0.011 | 0.086 | 0.005 | 0 | 0.007 | 0.071 | 0.054 | 0.003 | 0.013 | 0.007 | 0.003 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0.002 | 0.028 | 0.002 | 0.01 | 0.145 | -0 | 0 | 0.005 | 0 | 0 |
| Gross Profit
| 0.011 | 0.012 | 0.01 | 0.028 | 0.011 | 0.086 | 0.003 | -0.028 | 0.005 | 0.06 | -0.091 | 0.003 | 0.012 | 0.002 | 0.003 | 0 |
| Gross Profit Ratio
| 1 | 1 | 1 | 1 | 1 | 1 | 0.624 | 0 | 0.71 | 0.855 | -1.687 | 1.129 | 0.973 | 0.304 | 1 | 0.306 |
| Reseach & Development Expenses
| 0.033 | 0.022 | 0 | 0 | 0 | 0.142 | 0.165 | 0.1 | 0.091 | 0.129 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0.345 | 0.253 | -0.078 | 0.512 | 0.472 | 0.405 | 1.142 | 0.295 | 0.425 | 0.5 | 0.896 | 0.484 | 0.196 | 0.22 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0.345 | 0.253 | -0.078 | 0.512 | 0.472 | 0.405 | 1.142 | 0.295 | 0.425 | 0.5 | 0.896 | 0.484 | 0.196 | 0.22 | 1.836 | 0 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 0.378 | 0.276 | 0.342 | 0.512 | 0.472 | 0.405 | 0.821 | 0.395 | 0.425 | 0.5 | 0.896 | 0.484 | 0.196 | 0.22 | 1.836 | 0 |
| Operating Income
| -0.367 | -0.264 | -0.331 | -0.485 | -0.461 | -0.319 | -0.818 | -0.423 | -0.421 | -0.44 | -0.987 | -0.481 | -0.184 | -0.218 | -1.833 | -0.001 |
| Operating Income Ratio
| -32.894 | -22.807 | -31.824 | -17.584 | -41.676 | -3.707 | -161.256 | 0 | -63.303 | -6.223 | -18.33 | -182.108 | -14.659 | -33.506 | -629.67 | -34.47 |
| Total Other Income Expenses Net
| 0.025 | -0 | -0 | -0.002 | -0.031 | -0.001 | 0.055 | -0.006 | -0.028 | -0.026 | -0.487 | -3.522 | -0.209 | -0.254 | -2.58 | 0 |
| Income Before Tax
| -0.342 | -0.264 | -0.332 | -0.487 | -0.491 | -0.32 | -0.763 | -0.429 | -0.449 | -0.466 | -1.474 | -4.003 | -0.393 | -0.472 | -4.413 | -0 |
| Income Before Tax Ratio
| -30.63 | -22.837 | -31.863 | -17.67 | -44.437 | -3.721 | -150.43 | 0 | -67.506 | -6.586 | -27.374 | -1,515.232 | -31.28 | -72.41 | -1,515.864 | -27.114 |
| Income Tax Expense
| 0 | 0 | 0 | 0.04 | -0.121 | -0.042 | -0.054 | -0.027 | -0.086 | -0.06 | -2.419 | 0.623 | 0 | 0 | 0 | 0 |
| Net Income
| -0.342 | -0.264 | -0.332 | -0.487 | -0.491 | -0.32 | -0.763 | -0.429 | -0.449 | -0.466 | -1.474 | -4.003 | -0.393 | -0.472 | -4.413 | -0 |
| Net Income Ratio
| -30.63 | -22.837 | -31.863 | -17.67 | -44.437 | -3.721 | -150.43 | 0 | -67.506 | -6.586 | -27.374 | -1,515.232 | -31.28 | -72.41 | -1,515.864 | -27.114 |
| EPS
| -0.002 | -0.002 | -0.002 | -0.004 | -0.004 | -0.003 | -0.006 | -0.004 | -0.004 | -0.004 | -0.013 | -0.047 | -0.005 | -0.006 | -0.054 | -0.007 |
| EPS Diluted
| -0.002 | -0.002 | -0.002 | -0.004 | -0.004 | -0.003 | -0.006 | -0.004 | -0.004 | -0.004 | -0.013 | -0.047 | -0.005 | -0.006 | -0.054 | -0.007 |
| EBITDA
| -0.33 | -0.264 | -0.331 | -0.485 | -0.461 | -0.319 | -0.818 | -0.423 | -0.421 | -0.44 | -1.011 | -3.38 | -0.184 | -0.218 | -4.215 | -0.001 |
| EBITDA Ratio
| -29.55 | -22.807 | -31.824 | -17.584 | -41.676 | -3.707 | -161.149 | 0 | -63.303 | -6.223 | -18.763 | -1,279.446 | -14.647 | -33.447 | -1,447.878 | -34.423 |